Epidemiological investigation reveals a shared source for Candida pelliculosa joint infections after outpatient injections, highlighting risks of extrinsically contaminated medication.
In June 2022 a cluster of two cases of Candida pelliculosa osteoarticular infections was identified among patients who received joint injections at an outpatient facility. Isolate whole-genome sequencing analysis, combined with infection prevention and control observations at the facility suggested a common source of infection, potentially from extrinsically contaminated medication.
No takes yet. Share an insight, caveat, or question.
Misas et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: